We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") has been granted Canadian Patent 2,283,280 entitled "Reovirus for the treatment of neoplasia."
Nigerian government body the Pharmaceutical Council (PCN) claims that local drugmakers need to take a more active role in combating copy and fake drugs.
Japan's finance ministry is lobbying top government officials for new drug cost-containment mechanisms. Under the proposed initiative, patients would be obliged to cover the price gap between the reference innovative product and the appropriate generic with co-payments.
Governments must cooperate to stop the global spread of counterfeit drugs, most
of which come from India and China, two of the world's biggest pharmaceutical
firms said on Wednesday.
Dutch chemicals company Akzo Nobel reported a 66 percent drop in third-quarter
profit Wednesday, in part because last year's earnings benefited by a one-time
sale of assets.
Amid rising global panic over a bird flu epidemic, the Korea Food and Drug Administration
said Wednesday it could override trademark regulations to allow Korea to produce
generic versions of the anti-influenza Tamiflu to prepare for any outbreak among
humans.
South Africa's largest generic drug company Enaleni Pharmaceuticals is planning
to sue Lupin the Rs 1,200 crore domestic pharma major for terminating a marketing
right unilaterally in violation of an existing agreement.